Lance Berberian V.'s most recent trade in Laboratory Corp. Of America Holdings was a trade of 3,325 Common Stock done . Disclosure was reported to the exchange on March 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Labcorp | Lance V. Berberian | EVP, Special Advisor, Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2025 | 3,325 | 20,005 (0%) | 0% | 0 | Common Stock | |
| Labcorp | Lance V. Berberian | EVP, Special Advisor, Strategy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 231.67 per share. | 27 Mar 2025 | 1,353 | 18,652 (0%) | 0% | 231.7 | 313,450 | Common Stock |
| Labcorp | Lance V. Berberian | EVP, Special Advisor, Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 323 | 16,766 (0%) | 0% | - | Common Stock | |
| Labcorp | Lance V. Berberian | EVP, Special Advisor, Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 323 | 1,067 | - | - | Restricted Stock Unit | |
| Labcorp | Lance V. Berberian | EVP, Special Advisor, Strategy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 245.14 per share. | 11 Feb 2025 | 86 | 16,680 (0%) | 0% | 245.1 | 21,082 | Common Stock |
| Labcorp | Lance V. Berberian | EVP, Special Advisor, Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 356 | 16,277 (0%) | 0% | - | Common Stock | |
| Labcorp | Lance V. Berberian | EVP, Special Advisor, Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 356 | 1,744 | - | - | Restricted Stock Unit | |
| Labcorp | Lance V. Berberian | EVP, Special Advisor, Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 354 | 1,390 | - | - | Restricted Stock Unit | |
| Labcorp | Lance V. Berberian | EVP, Special Advisor, Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 354 | 16,537 (0%) | 0% | - | Common Stock | |
| Labcorp | Lance V. Berberian | EVP, Special Advisor, Strategy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 247.74 per share. | 06 Feb 2025 | 94 | 16,183 (0%) | 0% | 247.7 | 23,288 | Common Stock |
| Labcorp | Lance V. Berberian | EVP, Special Advisor, Strategy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 246.27 per share. | 06 Feb 2025 | 94 | 16,443 (0%) | 0% | 246.3 | 23,149 | Common Stock |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Sale of securities on an exchange or to another person at price $ 228.95 per share. | 05 Aug 2024 | 9,848 | 15,921 (0%) | 0% | 228.9 | 2,254,685 | Common Stock |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Sale of securities on an exchange or to another person at price $ 229.78 per share. | 05 Aug 2024 | 2,245 | 25,769 (0%) | 0% | 229.8 | 515,867 | Common Stock |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2024 | 7,697 | 2,100 | - | - | Restricted Stock Unit | |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2024 | 7,697 | 31,313 (0%) | 0% | - | Common Stock | |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 216.57 per share. | 27 Mar 2024 | 3,299 | 28,014 (0%) | 0% | 216.6 | 714,464 | Common Stock |
| Labcorp | Berberian V. Lance | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2024 | 324 | 23,703 (0%) | 0% | - | Common Stock | |
| Labcorp | Lance Berberian V. | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2024 | 324 | 9,797 | - | - | Restricted Stock Unit | |
| Labcorp | Berberian Lance V. | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 227.45 per share. | 11 Feb 2024 | 87 | 23,616 (0%) | 0% | 227.4 | 19,788 | Common Stock |
| Labcorp | Lance Berberian V. | EVP, CIO & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 3,300 | 3,300 | - | - | Non-qualified Stock Options | |
| Labcorp | Lance Berberian V. | EVP, CIO & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 1,070 | 10,474 | - | - | Restricted Stock Unit | |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 353 | 23,473 (0%) | 0% | - | Common Stock | |
| Labcorp | Berberian Lance V. | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 353 | 10,121 | - | - | Restricted Stock Unit | |
| Labcorp | V. Berberian Lance | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.71 per share. | 06 Feb 2024 | 94 | 23,379 (0%) | 0% | 223.7 | 21,029 | Common Stock |
| Labcorp | Berberian V. Lance | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 331 | 23,209 (0%) | 0% | - | Common Stock | |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 331 | 9,404 | - | - | Restricted Stock Unit | |
| Labcorp | V. Lance Berberian | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 221.54 per share. | 02 Feb 2024 | 89 | 23,120 (0%) | 0% | 221.5 | 19,717 | Common Stock |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 7,758 | 9,585 | - | - | Restricted Stock Unit | |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2023 | 4,509 | 24,677 (0%) | 0% | 0 | Common Stock | |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 224.70 per share. | 30 Mar 2023 | 1,799 | 22,878 (0%) | 0% | 224.7 | 404,235 | Common Stock |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 290 | 1,827 | - | - | Restricted Stock Unit | |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 290 | 20,253 (0%) | 0% | - | Common Stock | |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 248.13 per share. | 11 Feb 2023 | 85 | 20,168 (0%) | 0% | 248.1 | 21,091 | Common Stock |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 3,000 | 3,000 | - | - | Non-qualified Stock Options | |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 950 | 2,117 | - | - | Restricted Stock Unit | |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2023 | 374 | 20,071 (0%) | 0% | - | Common Stock | |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2023 | 374 | 1,167 | - | - | Restricted Stock Unit | |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 244.50 per share. | 04 Feb 2023 | 108 | 19,963 (0%) | 0% | 244.5 | 26,406 | Common Stock |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2023 | 297 | 19,799 (0%) | 0% | - | Common Stock | |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2023 | 297 | 1,541 | - | - | Restricted Stock Unit | |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 254.99 per share. | 02 Feb 2023 | 102 | 19,697 (0%) | 0% | 255.0 | 26,009 | Common Stock |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2022 | 5,310 | 21,862 (0%) | 0% | 0 | Common Stock | |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 276.42 per share. | 27 Mar 2022 | 2,360 | 19,502 (0%) | 0% | 276.4 | 652,351 | Common Stock |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 3,100 | 3,100 | - | - | Non-qualified Stock Options | |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2022 | 2,354 | 16,997 (0%) | 0% | - | Common Stock | |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2022 | 2,354 | 2,192 | - | - | Restricted Stock Unit | |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 870 | 4,546 | - | - | Restricted Stock Unit | |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 272.68 per share. | 11 Feb 2022 | 694 | 16,657 (0%) | 0% | 272.7 | 189,240 | Common Stock |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2022 | 354 | 17,351 (0%) | 0% | - | Common Stock | |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2022 | 354 | 1,838 | - | - | Restricted Stock Unit | |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 272.68 per share. | 11 Feb 2022 | 105 | 16,552 (0%) | 0% | 272.7 | 28,631 | Common Stock |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2022 | 373 | 14,752 (0%) | 0% | - | Common Stock | |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2022 | 373 | 3,676 | - | - | Restricted Stock Unit | |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 277.48 per share. | 04 Feb 2022 | 109 | 14,643 (0%) | 0% | 277.5 | 30,245 | Common Stock |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2022 | 296 | 14,482 (0%) | 0% | - | Common Stock | |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2022 | 296 | 4,049 | - | - | Restricted Stock Unit | |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 273.18 per share. | 02 Feb 2022 | 103 | 14,379 (0%) | 0% | 273.2 | 28,138 | Common Stock |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2021 | 2,413 | 15,265 (0%) | 0% | 0 | Common Stock | |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 251.58 per share. | 27 Mar 2021 | 1,079 | 14,186 (0%) | 0% | 251.6 | 271,455 | Common Stock |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 2,353 | 4,698 | - | - | Restricted Stock Unit | |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 2,353 | 13,303 (0%) | 0% | - | Common Stock | |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 238.26 per share. | 12 Feb 2021 | 699 | 12,604 (0%) | 0% | 238.3 | 166,544 | Common Stock |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 353 | 12,957 (0%) | 0% | - | Common Stock | |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 353 | 4,345 | - | - | Restricted Stock Unit | |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 234 | 7,051 | - | - | Restricted Stock Unit | |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 234 | 11,019 (0%) | 0% | - | Common Stock | |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 238.26 per share. | 12 Feb 2021 | 105 | 12,852 (0%) | 0% | 238.3 | 25,017 | Common Stock |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 238.26 per share. | 12 Feb 2021 | 69 | 10,950 (0%) | 0% | 238.3 | 16,440 | Common Stock |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2021 | 373 | 10,916 (0%) | 0% | - | Common Stock | |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2021 | 373 | 7,285 | - | - | Restricted Stock Unit | |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.78 per share. | 04 Feb 2021 | 131 | 10,785 (0%) | 0% | 223.8 | 29,315 | Common Stock |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2021 | 3,100 | 3,100 | - | - | Non-qualified Stock Options | |
| Labcorp | Lance V. Berberian | EVP, CIO & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2021 | 890 | 7,658 | - | - | Restricted Stock Unit |